ARTICLE | Distillery Therapeutics
Neurology
July 31, 2017 7:20 PM UTC
Cell culture studies suggest inhibiting DISC1-FBXW7 binding could help treat schizophrenia and major depressive disorder (MDD). In human neuroprogenitor cells (NPCs) differentiated from induced plurip...
BCIQ Company Profiles